Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2020
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study)Annika Kurreck, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2018
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110)Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, et al.Frontiers in Oncology|March 7, 2022
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI TrialAnnika Kurreck, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.Frontiers in Immunology|December 11, 2024
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patientsJonas S Heitmann, Susanne Jung, Marcel Wacker, et al.British Journal of Cancer|May 31, 2022
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3Laura E Fischer, Sebastian Stintzing, Ludwig Fischer von Weikersthal, et al.Pageof 3